EP08.01-018 Patterns of Failure in Metastatic NSCLC Treated with First Line Pembrolizumab and Impact of Local Therapy in Patients with Oligoprogression

Autor: Friedes, C., Yegya-Raman, N., Aggarwal, C., Marmarelis, M., Cohen, R., Levin, W., Cengel, K., Ciunci, C., Kosteva, J., Singh, A., Robinson, K., Sun, L., D'Avella, C., Davis, C., Langer, C., Feigenberg, S.

Publikováno v: In Journal of Thoracic Oncology September 2022 17(9) Supplement:S345-S345

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Electronic Medical Record-Based Nudge Intervention to Increase Comprehensive Molecular Genotyping in Patients With Metastatic Non-Small Cell Lung Cancer: Results From a Prospective Clinical Trial.

Autor: Marmarelis ME; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Scholes DG; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., McWilliams TL; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA.; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA., Hwang WT; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, PA.; Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA., Kosteva J; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Costello MR; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Sun L; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Singh AP; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Lau-Min KS; Division of Hematology-Oncology, Massachusetts General Cancer Center, Boston, MA., Doucette A; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., Gabriel PE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Martella AO; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., Roy MA; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Thompson JC; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Department of Pulmonary Medicine and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Cohen RB; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Dougherty DW; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Shulman LN; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA., Langer CJ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Bekelman JE; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA.; Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Carpenter EL; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Aggarwal C; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.; Penn Center for Cancer Care Innovation, University of Pennsylvania, Philadelphia, PA.

Publikováno v: JCO oncology practice [JCO Oncol Pract] 2024 Dec; Vol. 20 (12), pp. 1620-1628. Date of Electronic Publication: 2024 Jul 03.